Triple
T6065086
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | SMN2 |
E135135
|
entity |
| Predicate | targetOfDrug |
P37016
|
FINISHED |
| Object |
branaplam
Branaplam is an investigational small-molecule splicing modulator originally developed for spinal muscular atrophy that enhances SMN protein production by altering SMN2 pre-mRNA splicing.
|
E567204
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69c00878d06881909ee78e88913bf890 |
elicitation | completed |
| NER | batch_69c05723c91c819090b4d4672e72f9f3 |
ner | completed |
| NED1 | batch_69c11d23dca8819080702ca0f05df5dd |
ned_source_triple | completed |
| NED2 | batch_69c11e5efd848190adb834e42b4bdc9e |
ned_description | completed |
| NEDg | batch_69c11dec348c819090715aa1ec407f11 |
nedg | completed |
Created at: March 22, 2026, 4:10 p.m.